Clinical Trial

Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma

Name: Safety And Effectiveness Of NaviFUS System With Bevacizumab In Recurrent Glioblastoma — clinical trial record (NCT07274787)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

Not Yet Recruiting

View on ClinicalTrials.gov →

Summary

This study will evaluate the safety and early effectiveness of the NaviFUS system with concomitant microbubble administration in conjunction with BEV in recurrent GBM patients.

Protocol Amendment History 1 amendment

This ClinicalTrials.gov record has been amended once since 2025-12-09.

Trial Details

NCT Number	NCT07274787
Lead Sponsor	University of Cincinnati Collaborators: NaviFUS Corporation
Conditions	GBM
Enrollment	10 participants
Start Date	2026-12-01
Primary Completion	2028-12-01 (estimated)
Study Completion	2029-12-01 (estimated)
Updated on ClinicalTrials.gov	2026-06-04